Clinical trials recruiting in Kiev, Ukraine
7
Recruiting trials
15
Conditions
Phase breakdown
Phase 1 1Phase 2 2Phase 3 4
Conditions recruiting in Kiev, Ukraine
Recruiting trials in Kiev, Ukraine
- A Long-term Extension Study of PCI-32765 (Ibrutinib)
- A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
- A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)
- A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)
- LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
- Pharmacokinetic Similarity Study to Compare AVT32-DRL_PB With Keytruda® in Participants With Fully Resected Melanoma
- Study to Evaluate Tulisokibart in Adults With Psoriatic Arthritis (MK-7240-015)
Common questions
How many clinical trials are recruiting in Kiev, Ukraine?
7 recruiting trials have at least one study site in Kiev, Ukraine.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.